|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0032718,
umls-concept:C0034897,
umls-concept:C0205225,
umls-concept:C0439807,
umls-concept:C0441767,
umls-concept:C0728940,
umls-concept:C1512948,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C2239176
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-12-16
|
|
pubmed:abstractText |
Hepatectomy is now considered as the most effective treatment for hepatocellular carcinoma (HCC). High recurrence rate after operation is the main factor to impact the curative effect. The options of treatment for preventing postoperative recurrence of HCC are controversial. This study was to explore the value of postoperative portal vein chemotherapy (PVC) in delaying recurrence of stage II HCC, and to evaluate the risk factors of recurrence.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1000-467X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1297-301
|
|
pubmed:meshHeading |
pubmed-meshheading:19079997-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19079997-Carcinoma, Hepatocellular,
pubmed-meshheading:19079997-Combined Modality Therapy,
pubmed-meshheading:19079997-Disease-Free Survival,
pubmed-meshheading:19079997-Female,
pubmed-meshheading:19079997-Follow-Up Studies,
pubmed-meshheading:19079997-Hepatectomy,
pubmed-meshheading:19079997-Humans,
pubmed-meshheading:19079997-Infusions, Intravenous,
pubmed-meshheading:19079997-Liver Neoplasms,
pubmed-meshheading:19079997-Male,
pubmed-meshheading:19079997-Middle Aged,
pubmed-meshheading:19079997-Neoplasm Recurrence, Local,
pubmed-meshheading:19079997-Neoplasm Staging,
pubmed-meshheading:19079997-Neoplastic Cells, Circulating,
pubmed-meshheading:19079997-Portal Vein,
pubmed-meshheading:19079997-Proportional Hazards Models,
pubmed-meshheading:19079997-Survival Rate
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
[The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
|
|
pubmed:affiliation |
Department of Hepatobiliary Surgery, Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, 830011, PR China. hf930131@qq.com
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Randomized Controlled Trial
|
